Jennison Associates
TECH icon

Jennison Associates’s Bio-Techne TECH Stock Holding History

Jennison Associates’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-119,213
Closed -$6.23M – 623
2026
Q1 		$6.23M Buy
+119,213
New +$7.16M ﹤0.01% 414
2023
Q1 		– Sell
-160,972
Closed -$13.3M – 627
2022
Q4 		$13.3M Sell
160,972
-55,068
-25% -$4.37M 0.01% 373
2022
Q3 		$15.3M Buy
216,040
+57,012
+36% +$4.93M 0.02% 347
2022
Q2 		$13.8M Sell
159,028
-7,040
-4% -$660K 0.01% 359
2022
Q1 		$18M Buy
166,068
+41,288
+33% +$4.26M 0.01% 363
2021
Q4 		$16.1M Buy
+124,780
New +$15.3M 0.01% 398

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Jennison Associates's TECH Position: Q2 2026 in Review

Jennison Associates sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 119,213 shares — an estimated $6.23M sold.

Jennison Associates first reported a position in TECH in Q4 2021 and held it in 6 quarters. The position peaked at $18M in Q1 2022. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Jennison Associates reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Jennison Associates sold 119,213 Bio-Techne shares in Q2 2026, an estimated $6.23M.
  • Jennison Associates first reported a position in Bio-Techne in Q4 2021 and held it in 6 quarters.
  • Jennison Associates's Bio-Techne position peaked at $18M in Q1 2022.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.